跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
醋酸艾替班特注射液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Icatibant Acetate Injection
Approved
化学药品
Icatibant Acetate Injection
TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH
🇨🇳 National Medical Products Administration
Approval Date
Apr 7, 2021
Approval ID
887U5ADQRmg
Company
TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH
Type
化学药品
Approval Details
Approval Id
887U5ADQRmg
Approval Number
国药准字HJ20210024
Generic Name
醋酸艾替班特注射液
Generic Name En
Icatibant Acetate Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
3ml: 30mg(按C₅₉H₈₉N₁₉O₁₃S计)
Reg Date
2021-04-07
Expired Date
2026-04-06
Company Name
TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH
Production Company Name
Vetter Pharma-Fertigung GmbH & Co. KG
Company Detail Path
/organization/takeda-pharmaceuticals-international-ag-ireland-branch
Production Company Detail Path
/organization/vetter-pharma-fertigung-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 7, 2021
Approval ID
887U5ADQRmg
Type
化学药品
Back to NMPA Approvals